Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells.
about
HMG-CoA reductase inhibitors and P-glycoprotein modulationSelective modulation of P-glycoprotein-mediated drug resistanceQuantitative Assessment of the Influence of Rhizoma Zingiberis on the Level of Aconitine in Rat Gut Sacs and Qualitative Analysis of the Major Influencing Components of Rhizoma Zingiberis on Aconitine Using UPLC/MSBeyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancersEquilibrated atomic models of outward-facing P-glycoprotein and effect of ATP binding on structural dynamics.New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents.Docking applied to the prediction of the affinity of compounds to P-glycoproteinMolecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185----Val-185 substitution in P-glycoprotein.Chemical specificity of the PDR5 multidrug resistance gene product of Saccharomyces cerevisiae based on studies with tri-n-alkyltin chlorides.Arene-Ru(II)-chloroquine complexes interact with DNA, induce apoptosis on human lymphoid cell lines and display low toxicity to normal mammalian cells.Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen.Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance.Cell biological mechanisms of multidrug resistance in tumors.A polymeric colchicinoid prodrug with reduced toxicity and improved efficacy for vascular disruption in cancer therapyEffect of rifampicin on pravastatin pharmacokinetics in healthy subjects.3,5-Bis(benzylidene)-4-oxo-1-phosphonopiperidines and related diethyl esters: Potent cytotoxins with multi-drug-resistance reverting properties.Control of Mycosphaerella graminicola on wheat seedlings by medical drugs known to modulate the activity of ATP-binding cassette transportersInteraction of multidrug-resistant Chinese hamster ovary cells with amphiphilesChanges in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells.Cyclosporin A and verapamil have different effects on energy metabolism in multidrug-resistant tumour cells.SDZ 280-446, a novel semi-synthetic cyclopeptolide: in vitro and in vivo circumvention of the P-glycoprotein-mediated tumour cell multidrug resistance.CPT-11 sensitivity in relation to the expression of P170-glycoprotein and multidrug resistance-associated proteinMultidrug resistance (mdr) genes in human cancer.Changes in intra- or extracellular pH do not mediate P-glycoprotein-dependent multidrug resistance.Functional expression of P-glycoprotein in Saccharomyces cerevisiae confers cellular resistance to the immunosuppressive and antifungal agent FK520.Functional expression of P-glycoprotein encoded by the mouse mdr3 gene in yeast cellsSynthesis, characterization, and in vitro antimalarial and antitumor activity of new ruthenium(II) complexes of chloroquine.Synergistic effects of A-B-C-type amphiphilic copolymer on reversal of drug resistance in MCF-7/ADR breast carcinoma.From delocalized lipophilic cations to hypoxia: blocking tumor cell mitochondrial function leads to therapeutic gain with glycolytic inhibitors.Repurposing Drugs in Oncology (ReDO)-Propranolol as an anti-cancer agentFunctional expression of mouse Mdr1 in an outer membrane permeability mutant of Escherichia coli.Secondary Metabolites from Plants Inhibiting ABC Transporters and Reversing Resistance of Cancer Cells and Microbes to Cytotoxic and Antimicrobial Agents.Peptide-chlorambucil conjugates combat pgp-dependent drug effluxEffect of disposition of mannich antimalarial agents on their pharmacology and toxicology.Manipulation of the N-alkyl substituent in amodiaquine to overcome the verapamil-sensitive chloroquine resistance component.1-[4-(2-Aminoethoxy)phenylcarbonyl]-3,5-bis-(benzylidene)-4-oxopiperidines: a novel series of highly potent revertants of P-glycoprotein associated multidrug resistance.Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein.Fluoxetine hydrochloride enhances in vitro susceptibility to chloroquine in resistant Plasmodium falciparum.Modulation of P-glycoprotein activity by cannabinoid molecules in HK-2 renal cells.Structural recognition of tubulysin B derivatives by multidrug resistance efflux transporters in human cancer cells.
P2860
Q28360140-A59F22CD-2789-4B01-A1A7-6D927B905F08Q28366597-51C24B6E-E045-4F03-A59D-7C73B340ADB9Q28547282-4338D6ED-35BF-4665-8C02-8417EDBD2AC0Q28743513-BB57B971-DAAC-4CF7-B127-F03DD6108F73Q30636997-AE170179-B74C-473E-9176-E3F5F8246E2AQ33652585-109361BE-63A1-4450-AC35-5E5F01DEC087Q33757813-40B2E490-1CDD-46AB-8884-56482F992C97Q33800929-F0614BBA-DD8F-43D8-95E4-D8955CCD8A9AQ33978498-FB218441-731C-4E6C-B174-F6C317D81532Q34020456-37B081A5-DAA2-442E-8C20-7DA16AD8954FQ34218136-758FF5DF-36AD-4AF1-A32B-9AAD669D6DEBQ34287731-22FE0E18-0A88-4E6C-826A-F1CE0688E139Q35179585-5A6A9C02-616B-4C66-850B-40A0783BD2E5Q35556939-691FE09B-5202-436A-AA48-A8FA2FF3CF49Q35825922-18CB40A2-1E76-4ABF-B24A-17D78F251291Q35941725-5B0A0C66-780C-44AB-9D98-93E4F99FEC1DQ35946793-2F512687-5088-4C5B-BDF6-E57914DBAE2FQ35977177-8ADBF8D7-0062-47F9-8324-4FCD4B388359Q35977902-1A2AC62C-3A3D-417C-86B1-2143FC213743Q35982832-0BB636EF-B11B-4093-AE92-D5E64BCA1167Q35992919-3A7EA96A-66FE-4955-B02C-9D93F439E657Q36295072-6ABB078D-AC33-459C-ABBB-101DD7D3BF57Q36495579-E4D9163E-F4C6-4845-BBCB-A5CF5514331FQ36609855-D010184E-32BC-4CEE-887E-5C1B8D984F69Q36643297-844DBA5B-3624-4DEB-8572-F7588ED86D29Q36715176-D6420E57-0A47-4362-B6B6-043F0D3FBFCFQ37169192-950C5493-A9C0-49A9-9E40-B821A86D3781Q37344258-50C0DED1-FA1B-4BC5-BA07-E1DED3302C1EQ37346228-F0BC9CBA-A5AF-4AAD-AE4A-BA8242D399A4Q37404693-2C17FA29-B3B0-4DB8-9111-3C6D8A64F0D8Q37565994-E9633DB3-2B5F-4765-8EB4-FCCFBB0C83ABQ38005689-F7834FA5-5F6F-4491-9F2D-1B3300538959Q39508030-0E088593-05A4-41CF-8D6C-CCD7DCC6D282Q39558835-B2718266-1095-484F-8E6B-945E3F8CAE21Q39782956-E0BD35A4-C74E-40A3-B199-438D9A7FC682Q39976884-3845E380-2B64-4EE1-BD4E-61AD4B7ECD77Q39998933-173494B9-8B09-4E2A-ABC4-AFE0EE89B6B7Q40088905-5E37BA1A-9818-4AFD-BE1E-A65113B84B4BQ40277195-DE7999E0-955C-475D-BF2E-AD736C6792ECQ41472858-D3A8A049-6916-43D4-8651-514DC459749E
P2860
Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Physical-chemical properties s ...... tance in human leukemic cells.
@en
type
label
Physical-chemical properties s ...... tance in human leukemic cells.
@en
prefLabel
Physical-chemical properties s ...... tance in human leukemic cells.
@en
P2093
P1476
Physical-chemical properties s ...... stance in human leukemic cells
@en
P2093
P304
P577
1988-04-01T00:00:00Z